Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
In recent years, there have been multiple advances in imaging technologies that have improved the surveillance for recurrence of neoplasms. Multidetector row CT and dynamic contrast enhanced MRI now provide excellent anatomic detail and are beginning to show functional detail as the rapid capture of images following contrast administration improves. Positron emission tomography is emerging as a useful tool in evaluating patients with suspected metastatic disease to the abdomen and bone, particularly when combined with CT. The role of ultrasound in the surveillance of renal cell carcinoma is yet unclear, but its role may be expanding with use of newly developed contrast drugs. Herein we review the relevance of these modalities to the follow-up of patients with renal cell carcinoma.
- Janzen NK, Kim HL, Figlin RA, Belldegrun AS: Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003, 30:843–852. CrossRef
- Frank I, Blute ML, Cheville JC, et al.: A multifactorial post-operative surveillance model for patients with surgically treated clear cell renal cell carcinoma. J Urol 2003, 170:2225–2232. CrossRef
- Lam JS, Leppert JT, Figlin RA, Belldegrun AS: Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr Urol Rep 2005, 6:7–18. CrossRef
- Frank I, Blute ML, Cheville JC: An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 2002, 168:2395–2400. CrossRef
- Itano NB, Blute ML, Spotts B, Zincke H: Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol 2000, 1640:322–325.
- Blath RA, Mancilla-Jimenez R, Stanley RJ: Clinical comparison between vascular and avascular renal cell carcinoma. J Urol 1976, 115:514–519.
- Jacobsen J, Grankvist K, Rasmuson T, Ljungberg B: Different isoform patterns for vascular endothelial growth factor between clear cell and papillary renal cell carcinoma. BJU Int 2006, 97:1102–1108. CrossRef
- Lang EK, Thomas R, Davis R, et al.: Multiphasic helical CT criteria for differentiation of recurrent neoplasm and desmoplastic reaction after laparoscopic resection of renal mass lesions. J Endourol 2004, 18:167–171. CrossRef
- Thomsen HS, Morcos SK: Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines. Eur Radiol 2006, 16:1835–1840. CrossRef
- McCullough PA, Soman SS: Contrast-induced nephropathy. Crit Care Clin 2005, 21:261–280. CrossRef
- Goldenberg I, Shechter M, Matetzky S, et al.: Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature. Eur Heart J 2004, 25:212–218. CrossRef
- Pannu N, Wiebe N, Tonelli M: Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006, 295:2765–2779. CrossRef
- Lawrentschuk N, Gani J, Riordan R, et al.: Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review. BJU Int 2005, 96:291–295. CrossRef
- Tuite DJ, Geoghegan T, McCauley G, et al.: Three-dimensional gadolinium-enhanced magnetic resonance breath-hold FLASH imaging in the diagnosis and staging of renal cell carcinoma. Clin Radiol 2006, 61:23–30. CrossRef
- Remer EM, Weinberg EJ, Oto A, et al.: MR imaging of the kidneys after laparoscopic cryoablation. AJR Am J Roentgenol 2000, 174:635–640.
- Zhu Q, Shimizu T, Endo H, et al.: Assessment of renal cell carcinoma after cryoablation using contrast-enhanced gray-scale ultrasound: a case series. Clin Imaging 2005, 29:102–108. CrossRef
- Motzer RJ, Bacik J, Schwartz LH, et al.: Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol 2004, 22:454–463. CrossRef
- Henschke CI, McCauley DI, Yankelevitz DF, et al.: Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999, 354:99–105. CrossRef
- Wagner AA, Solomon SB, Kavoussi LR: Imaging following cryoablation of a renal lesion. Nat Clin Pract Urol 2005, 2:52–57. CrossRef
- Hoh CK, Seltzer MA, Franklin J, et al.: Positron emission tomography in urological oncology. J Urol 1998, 159:347–356. CrossRef
- Miyakita H, Tokunaga M, Onda H, et al.: Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer. Int J Urol 2002, 9:15–18. CrossRef
- Ramdave S, Thomas GW, Berlangieri SU, et al.: Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol 2001, 166:825–830. CrossRef
- Safaei A, Figlin R, Hoh CK, et al.: The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol 2002, 57:56–62.
- Townsend DW, Beyer T: A combined PET/CT scanner: the path to true image fusion. Br J Radiol 2002, 75:S24–S30.
- Wu HC, Yen RF, Shen YY, et al.: Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas — a preliminary report. J Cancer Res Clin Oncol 2002, 128:503–506. CrossRef
- Peterson JJ, Kransdorf MJ, O’Connor MI: Diagnosis of occult bone metastases: positron emission tomography. Clin Orthop Relat Res 2003, (415 Suppl):S120–S128. CrossRef
- Payne BR, Prasad D, Szeifert G, et al.: Gamma surgery for intracranial metastases from renal cell carcinoma. J Neurosurg 2000, 92:760–765. CrossRef
- Wang JH, Min PQ, Wang PJ, et al.: Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. AJR Am J Roentgenol 2006, 186:1423–1430. CrossRef
- Hackstein N, Wiegand C, Rau WS, et al.: Glomerular filtration rate measured by using triphasic helical CT with a two-point Patlak plot technique. Radiology 2004, 230:221–226. CrossRef
- Harisinghani MG, Barentsz J, Hahn PF, et al.: Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003, 348:2491–2499. CrossRef
- Harisinghani MG, Saksena MA, Hahn PF, et al.: Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization? AJR Am J Roentgenol 2006, 186:144–148. CrossRef
- Sengupta S, Lohse CM, Leibovich BC, et al.: Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer 2005, 104:511–520. CrossRef
- Lawrentschuk N, Poon AM, Foo SS, et al.: Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography. BJU Int 2005, 96:540–546. CrossRef
- Bui MH, Seligson D, Han KR, et al.: Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 2003, 9:802–811.
- Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma
Current Urology Reports
Volume 8, Issue 1 , pp 38-43
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links